On December 15, 2021 China SXT Pharmaceuticals, Inc. announced, Jingzhen Deng, the Chief Scientific Officer and Chief Operation Officer notified the Company of his resignation from his positions of Chief Scientific Officer and Chief Operation Officer for personal reasons, effective immediately. His resignation was not a result of any disagreements with the Company on any matter related to the operations, policies, or practices of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +7.56% |
|
+23.08% | -67.76% |
1st Jan change | Capi. | |
---|---|---|
-67.76% | 932K | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- SXTC Stock
- News China SXT Pharmaceuticals, Inc.
- China SXT Pharmaceuticals, Inc. Announces Resignation of Jingzhen Deng as Chief Scientific Officer and Chief Operation Officer